These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 16517709

  • 1. Induction of alloreactive CD4 T cell tolerance in molecular chimeras: a possible role for regulatory T cells.
    Forman D, Kang ES, Tian C, Paez-Cortez J, Iacomini J.
    J Immunol; 2006 Mar 15; 176(6):3410-6. PubMed ID: 16517709
    [Abstract] [Full Text] [Related]

  • 2. Intrathymic deletion of alloreactive T cells in mixed bone marrow chimeras prepared with a nonmyeloablative conditioning regimen.
    Manilay JO, Pearson DA, Sergio JJ, Swenson KG, Sykes M.
    Transplantation; 1998 Jul 15; 66(1):96-102. PubMed ID: 9679828
    [Abstract] [Full Text] [Related]

  • 3. Defining the requirements for peptide recognition in gene therapy-induced T cell tolerance.
    Bagley J, Wu Y, Sachs DH, Iacomini J.
    J Immunol; 2000 Nov 01; 165(9):4842-7. PubMed ID: 11046007
    [Abstract] [Full Text] [Related]

  • 4. Expression of antigen on mature lymphocytes is required to induce T cell tolerance by gene therapy.
    Tian C, Bagley J, Iacomini J.
    J Immunol; 2002 Oct 01; 169(7):3771-6. PubMed ID: 12244171
    [Abstract] [Full Text] [Related]

  • 5. Induction of central deletional T cell tolerance by gene therapy.
    Kang ES, Iacomini J.
    J Immunol; 2002 Aug 15; 169(4):1930-5. PubMed ID: 12165518
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Differential susceptibility of allogeneic targets to indirect CD4 immunity generates split tolerance.
    Chan WF, Razavy H, Anderson CC.
    J Immunol; 2008 Oct 01; 181(7):4603-12. PubMed ID: 18802062
    [Abstract] [Full Text] [Related]

  • 8. Tolerance to MHC class II disparate allografts through genetic modification of bone marrow.
    Jindra PT, Tripathi S, Tian C, Iacomini J, Bagley J.
    Gene Ther; 2013 May 01; 20(5):478-86. PubMed ID: 22833118
    [Abstract] [Full Text] [Related]

  • 9. Reconstitution ratio is critical for alloreactive T cell deletion and skin graft survival in mixed bone marrow chimeras.
    Taniguchi H, Abe M, Shirai T, Fukao K, Nakauchi H.
    J Immunol; 1995 Dec 15; 155(12):5631-6. PubMed ID: 7499847
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Conferring indirect allospecificity on CD4+CD25+ Tregs by TCR gene transfer favors transplantation tolerance in mice.
    Tsang JY, Tanriver Y, Jiang S, Xue SA, Ratnasothy K, Chen D, Stauss HJ, Bucy RP, Lombardi G, Lechler R.
    J Clin Invest; 2008 Nov 15; 118(11):3619-28. PubMed ID: 18846251
    [Abstract] [Full Text] [Related]

  • 12. Abrogation of antibody-mediated allograft rejection by regulatory CD4 T cells with indirect allospecificity.
    Callaghan CJ, Rouhani FJ, Negus MC, Curry AJ, Bolton EM, Bradley JA, Pettigrew GJ.
    J Immunol; 2007 Feb 15; 178(4):2221-8. PubMed ID: 17277127
    [Abstract] [Full Text] [Related]

  • 13. Donor MHC class II antigen is essential for induction of transplantation tolerance by bone marrow cells.
    Umemura A, Monaco AP, Maki T.
    J Immunol; 2000 May 01; 164(9):4452-7. PubMed ID: 10779744
    [Abstract] [Full Text] [Related]

  • 14. Graft-facilitating doses of ex vivo activated gammadelta T cells do not cause lethal murine graft-vs.-host disease.
    Drobyski WR, Majewski D, Hanson G.
    Biol Blood Marrow Transplant; 1999 May 01; 5(4):222-30. PubMed ID: 10465102
    [Abstract] [Full Text] [Related]

  • 15. Donor and recipient specific tolerance in cells from semi-allogeneic, H-2 subregion compatible or fully allogeneic bone marrow chimeras attributable to clonal deletion.
    Onoé K, Iwabuchi K, Iwabuchi C, Arase H, Hatakeyama S, Wambua PP, Fukushi N, Negishi I, Good RA, Ogasawara K.
    Immunobiology; 1989 Jun 01; 179(2-3):172-89. PubMed ID: 2793201
    [Abstract] [Full Text] [Related]

  • 16. CTLA-4 on alloreactive CD4 T cells interacts with recipient CD80/86 to promote tolerance.
    Kurtz J, Raval F, Vallot C, Der J, Sykes M.
    Blood; 2009 Apr 09; 113(15):3475-84. PubMed ID: 19179471
    [Abstract] [Full Text] [Related]

  • 17. Early regulation of CD8 T cell alloreactivity by CD4+CD25- T cells in recipients of anti-CD154 antibody and allogeneic BMT is followed by rapid peripheral deletion of donor-reactive CD8+ T cells, precluding a role for sustained regulation.
    Fehr T, Takeuchi Y, Kurtz J, Wekerle T, Sykes M.
    Eur J Immunol; 2005 Sep 09; 35(9):2679-90. PubMed ID: 16082727
    [Abstract] [Full Text] [Related]

  • 18. Mechanisms of early peripheral CD4 T-cell tolerance induction by anti-CD154 monoclonal antibody and allogeneic bone marrow transplantation: evidence for anergy and deletion but not regulatory cells.
    Kurtz J, Shaffer J, Lie A, Anosova N, Benichou G, Sykes M.
    Blood; 2004 Jun 01; 103(11):4336-43. PubMed ID: 14962909
    [Abstract] [Full Text] [Related]

  • 19. The replacement of graft endothelium by recipient-type cells conditions allograft rejection mediated by indirect pathway CD4+ T cells.
    Kapessidou Y, Habran C, Buonocore S, Flamand V, Barvais L, Goldman M, Braun MY.
    Transplantation; 2006 Aug 27; 82(4):582-91. PubMed ID: 16958183
    [Abstract] [Full Text] [Related]

  • 20. Induction of antigen-specific tolerance to bone marrow allografts with CD4+CD25+ T lymphocytes.
    Joffre O, Gorsse N, Romagnoli P, Hudrisier D, van Meerwijk JP.
    Blood; 2004 Jun 01; 103(11):4216-21. PubMed ID: 14976053
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.